ELDN Valuation

Eledon Pharmaceuticals Inc

Add to Watchlist

Advanced Chart

3.620

-0.11(-2.949%)1D

Overview
Forecast
Valuation
Earnings

ELDN Relative Valuation

ELDN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ELDN is overvalued; if below, it's undervalued.

Historical Valuation

Eledon Pharmaceuticals Inc (ELDN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.10. The fair price of Eledon Pharmaceuticals Inc (ELDN) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：3.62

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.89

P/B

Median3y

-0.73

Median5y

-0.15

-24.44

FCF Yield

Median3y

-65.29

Median5y

-56.17

Competitors Valuation Multiple

The average P/S ratio for ELDN's competitors is 19.87, providing a benchmark for relative valuation. Eledon Pharmaceuticals Inc Corp (ELDN) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

ELDN.O

Eledon Pharmaceuticals Inc

Loss

Average P/S: 19.87

216.77M